162 related articles for article (PubMed ID: 7954437)
1. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
Lorence RM; Katubig BB; Reichard KW; Reyes HM; Phuangsab A; Sassetti MD; Walter RJ; Peeples ME
Cancer Res; 1994 Dec; 54(23):6017-21. PubMed ID: 7954437
[TBL] [Abstract][Full Text] [Related]
2. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy.
Lorence RM; Reichard KW; Katubig BB; Reyes HM; Phuangsab A; Mitchell BR; Cascino CJ; Walter RJ; Peeples ME
J Natl Cancer Inst; 1994 Aug; 86(16):1228-33. PubMed ID: 8040891
[TBL] [Abstract][Full Text] [Related]
3. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration.
Phuangsab A; Lorence RM; Reichard KW; Peeples ME; Walter RJ
Cancer Lett; 2001 Oct; 172(1):27-36. PubMed ID: 11595126
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
[TBL] [Abstract][Full Text] [Related]
5. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.
Vigil A; Park MS; Martinez O; Chua MA; Xiao S; Cros JF; Martínez-Sobrido L; Woo SL; García-Sastre A
Cancer Res; 2007 Sep; 67(17):8285-92. PubMed ID: 17804743
[TBL] [Abstract][Full Text] [Related]
6. [Anti-tumor effect of Newcastle disease virus strain D817 against nude mouse xenografts of human colon carcinoma].
Huang C; Fan XH; Jiang YH; Song DZ; Gao LQ; Huang QG; Lai ZP
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):490-4. PubMed ID: 19950694
[TBL] [Abstract][Full Text] [Related]
7. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
[TBL] [Abstract][Full Text] [Related]
8. Newcastle disease virus selectively kills human tumor cells.
Reichard KW; Lorence RM; Cascino CJ; Peeples ME; Walter RJ; Fernando MB; Reyes HM; Greager JA
J Surg Res; 1992 May; 52(5):448-53. PubMed ID: 1619912
[TBL] [Abstract][Full Text] [Related]
9. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
10. Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Suit HD
Cancer Res; 1993 Oct; 53(20):5018-21. PubMed ID: 8402693
[TBL] [Abstract][Full Text] [Related]
11. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
12. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
13. Selective cytolysis of tumor cells by mumps virus S79.
Yan YF; Chen X; Zhu Y; Wu JG; Dong CY
Intervirology; 2005; 48(5):292-6. PubMed ID: 15956796
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
16. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Ruka W; Suit HD
Cancer Res; 1993 Oct; 53(20):5012-7. PubMed ID: 8402692
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
Wright P; Zheng C; Moyana T; Xiang J
Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
20. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
Pollack VA; Alvarez E; Tse KF; Torgov MY; Xie S; Shenoy SG; MacDougall JR; Arrol S; Zhong H; Gerwien RW; Hahne WF; Senter PD; Jeffers ME; Lichenstein HS; LaRochelle WJ
Cancer Chemother Pharmacol; 2007 Aug; 60(3):423-35. PubMed ID: 17541593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
